|Articles|May 10, 2013

LCGC Europe eNews

  • LCGC Europe eNews-05-10-2013
  • Volume 0
  • Issue 0

EMD Millipore and W.L. Gore & Associates, Inc. Settle Patent Infringement Dispute

Patent infringement disputes between EMD Millipore (Billerica, Massachusetts) and W.L. Gore and Associates Inc. (Delaware, USA) have been settled in the United States District Court for the District of Massachusetts, United States District Court for the District of New Jersey, and the United States District Court for the District of Delaware.

Patent infringement disputes between EMD Millipore (Billerica, Massachusetts) and W.L. Gore and Associates Inc. (Delaware, USA) have been settled in the United States District Court for the District of Massachusetts, United States District Court for the District of New Jersey, and the United States District Court for the District of Delaware.

Under the settlement terms, Gore will take a royalty-bearing license under U.S. Patent Nos. 7,293,744 and 7,927,316 and U.S. Reissue No. RE41,169 relating to the products disputed.

Andrew Bulpin, Executive Vice President for EMD Millipore Process Solutions, said: "Our customers rely on us to be technology leaders for innovation in biopharmaceutical production and, as such, EMD Millipore will continue to vigorously defend its intellectual property."

For more information please visit: www.emdmillipore.com

Articles in this issue


Related to this article

LC-MS/MS Method Detects Propofol via Metabolite
Koji Yamaguchi of the International University of Health and Welfare (Narita, Japan) discusses a novel derivatized liquid chromatography-tandem mass spectrometry (LC-MS/MS) method plus propofol glucuronide (PRG) marker which improves forensic propofol detection.